Hyperreactiv airway disease. Respiratory conditions due to unspecified external agent
Conditions
Interventions
Intervention 1: Intervention group: including 50 children aged 2 to 15 years with HRAD diagnosis receiving standard treatment (including short-acting beta-agonist spray (salbutamol) and antihistamine
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 15 Years
Inclusion criteria
Inclusion criteria: Children with airway hyperreactivity between 2 years and 15 years who have not recently used systemic or inhaled corticosteroids and are not known to have asthma. Absence of serious diseases that interfere with the research results (such as severe heart or lung diseases). Has not recently used long-term bronchodilators or theophylline.
Exclusion criteria
Exclusion criteria: patient with known asthma Other diagnoses such as pneumonia are relevant Recent treatment with systemic or inhaled corticosteroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Need to be hospitalized. Timepoint: At the beginning of the study and then every 3 days until the end of 2 weeks. Method of measurement: Clinical examination: pulmonary auscultation with a stethoscope, measurement of arterial oxygen with a pulse oximeter.;Duration of hospitalization. Timepoint: From the time of admission to the hospital until discharge on a daily basis. Method of measurement: Counting the number of days of hospitalization. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cough severity. Timepoint: At the beginning of the study and then every 3 days until the end of 2 weeks. Method of measurement: Based on the scoring system of a standardized 5-question questionnaire.;Cough frequency. Timepoint: At the beginning of the study and then every 3 days until the end of 2 weeks. Method of measurement: Based on the scoring system of a standardized 5-question questionnaire.;Nocturnal sleep disorder. Timepoint: At the beginning of the study and then every 3 days until the end of 2 weeks. Method of measurement: Based on the scoring system of a standardized 5-question questionnaire.;Pulmonary wheezing. Timepoint: At the beginning of the study and then every 3 days until the end of 2 weeks. Method of measurement: Clinical examination: pulmonary auscultation with a stethoscope.;Arterial oxygen saturation. Timepoint: at the beginning of the research and then every 3 days until the end of 2 weeks. Method of measurement: Clinical examination: measurement of arterial oxygen with a pulse oximeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSadegh Khalilian Shalamzari
Shahre-kord University of Medical Sciences
Outcome results
None listed